liu.seSearch for publications in DiVA
Change search
ReferencesLink to record
Permanent link

Direct link
Low antibiotic resistance rates in Staphylococcus aureus, Escherichia coli and Klebsiella spp but not in Enterobacter spp and Pseudomonas aeruginosa: A prospective observational study in 14 Swedish ICUs over a 5-year period
Linköping University, Department of Molecular and Clinical Medicine, Infectious Diseases. Linköping University, Faculty of Health Sciences. Östergötlands Läns Landsting, Centre for Medicine, Department of Infectious Diseases in Östergötland.
Linköping University, Department of Molecular and Clinical Medicine, Infectious Diseases. Linköping University, Faculty of Health Sciences.
Show others and affiliations
2007 (English)In: Acta Anaesthesiologica Scandinavica, ISSN 0001-5172, Vol. 51, no 7, 937-941 p.Article in journal (Refereed) Published
Abstract [en]

Background: Intensive care units (ICUs) are hot zones for emergence and spread of antibiotic resistance because of frequent invasive procedures, antibiotic usage and transmission of bacteria. We report prospective data on antibiotic use and bacterial resistance from 14 academic and non-academic ICUs, participating in the ICU-STRAMA programme 1999-2003. Methods: The quantity of antibiotics delivered to each ICU was calculated as defined daily doses per 1000 occupied bed days (DDD1000). Specimens for culture were taken on clinical indications and only initial isolates were considered. Species-related breakpoints according to the Swedish Reference Group for Antibiotics were used. Antibiotic resistance was defined as the sum of intermediate and resistant strains. Results: Mean antibiotic use increased from 1245 DDD1000 in 1999 to 1510 DDD1000 in 2003 (P = 0.11 for trend). Of Staphylococcus aureus, 0-1.8% were methicillin resistant (MRSA). A presumptive extended spectrum beta-lactamase (ESBL) phenotype was found in <2.4% of Escherichia coli, based on cefotaxime susceptibility, except a peak in 2002 (4.6%). Cefotaxime resistance was found in 2.6-4.9% of Klebsiella spp. Rates of resistance among Enterobacter spp. to cefotaxime (20-33%) and among Pseudomonas aeruginosa to imipenem (22-33%) and ciprofloxacin (5-21%) showed no time trend. Conclusion: MRSA and cefotaxime-resistant E. coli and Klebsiella spp strains were few despite high total antibiotic consumption. This may be the result of a slow introduction of resistant strains into the ICUs, and good infection control. The cause of imipenem and ciprofloxacin resistance in P. aeruginosa could reflect the increased consumption of these agents plus spread of resistant clones. © 2007 The Authors.

Place, publisher, year, edition, pages
2007. Vol. 51, no 7, 937-941 p.
National Category
Medical and Health Sciences
URN: urn:nbn:se:liu:diva-38187DOI: 10.1111/j.1399-6576.2007.01364.xLocal ID: 42370OAI: diva2:259036
STRAM study group, ICUAvailable from: 2009-10-10 Created: 2009-10-10 Last updated: 2010-01-25

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Hanberger, HåkanErlandsson, MarcusGill, HansNilsson, LennartWalther, Sten
By organisation
Infectious DiseasesFaculty of Health SciencesDepartment of Infectious Diseases in ÖstergötlandMedical InformaticsThe Institute of TechnologyClinical MicrobiologyPhysiologyDepartment of Thoracic and Vascular Surgery
In the same journal
Acta Anaesthesiologica Scandinavica
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 732 hits
ReferencesLink to record
Permanent link

Direct link